Stay informed with the latest litigation news. Explore now

IP Verse

Combination Of Direct Acting Antiviral Agents And Ribavirin For Treating Hcv Patients - EP2968302B9

EP2968302

ABBVIE
Application Number
EP14725812A
Filing Date
Mar 14, 2014
Status
Revoked
Sep 2, 2020
Grant Date
Feb 13, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3377110B1
EP2691134B2
EP3213750B1

Bibliography

The patent EP2968302B9 was granted to Abbvie on Feb 13, 2019 following the initial filing on Mar 14, 2014 under the application number EP14725812A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKJun 6, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents